Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Erdheim-Chester disease"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Case Reports
Case Report of Erdheim-Chester Disease Successfully Treated with Pegylated Interferon: A Single-Center Experience
Yujin Lim, Sang Eun Yoon, Junhun Cho, Darae Kim, Chul Won Jung
Cancer Res Treat. 2023;55(3):1053-1057.   Published online January 19, 2023
DOI: https://doi.org/10.4143/crt.2022.1535
AbstractAbstract PDFPubReaderePub
Erdheim-Chester disease (ECD), also known as non-Langerhans cell histiocytosis, is a multi-systemic disease with unclear pathogenesis. Based on a small number of case studies, pegylated interferon-α (PEG-IFN-α) has been used as the front-line treatment option. However, there are limited data regarding administration of ropegylated-interferon α-2b (ROPEG-IFN-α 2b) for ECD patients. Herein, we report two cases of severe ECD treated with two types of PEG-IFN-α. One patient with heart and skeleton involvement and BRAF V600E mutation was treated with weekly PEG-IFN-α 2a. Another patient with bone involvement and no BRAF V600E mutation was administered monthly ROPEG-IFN-α 2b. The two types of PEG-IFN-α showed excellent disease control, excellent survival outcomes, and manageable toxicities in ECD patients. These results suggest that ROPEG-IFN-α 2b could be used equivalently to PEG-IFN-α 2a for management of advanced ECD.

Citations

Citations to this article as recorded by  
  • An Autopsied Case of Erdheim-Chester Disease with Severe Cardiovascular Involvement
    Atsushi Matsunashi, Wang Zhipeng, Akihiko Sugimoto, Masakazu Fujimoto, Akihiko Yoshizawa, Ryo Sakamoto, Michihiro Uyama, Kohei Ikezoe, Kiminobu Tanizawa, Tomohiro Handa, Toyohiro Hirai
    Internal Medicine.2025;[Epub]     CrossRef
  • Recent advances in therapeutic strategies of Erdheim-Chester disease
    Rohit Doke, Rahul Lokhande, Kalyani Chande, Kuldeep Vinchurkar, Bhupendra G. Prajapati
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub]     CrossRef
  • Erdheim–Chester disease: Comprehensive insights from genetic mutations to clinical manifestations and therapeutic advances
    Rishabh Chaudhary, Anand Kumar, Alpana Singh, Vipul Agarwal, Mujeeba Rehman, Arjun Singh Kaushik, Siddhi Srivastava, Sukriti Srivastava, Vikas Mishra
    Disease-a-Month.2025; 71(2): 101845.     CrossRef
  • Advances in Understanding and Management of Erdheim-Chester Disease
    Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, Jesil Mathew Aranjani
    Life Sciences.2024; 348: 122692.     CrossRef
  • 3,838 View
  • 166 Download
  • 4 Web of Science
  • 4 Crossref
Close layer
Erdheim-Chester Disease with Emperipolesis: A Unique Case Involving the Heart
Pengcheng Zhu, Naping Li, Lu Yu, Mariajose Navia Miranda, Guoping Wang, Yaqi Duan
Cancer Res Treat. 2017;49(2):553-558.   Published online July 28, 2016
DOI: https://doi.org/10.4143/crt.2016.078
AbstractAbstract PDFPubReaderePub
Histiocytosis is an uncommon disease characterized by excessive accumulation of histiocytes. Here, we report a rare case of non-Langerhans-cell histiocytosis in a 51- year-old woman who presented with severe symptoms of pericardial effusion. Radiologic investigation also detected multiple bone (lower limbs, vertebrae, ribs, and ilium) lesions. Resected pericardium showed abundant mono- or multi-nucleated non-foamy histiocytes (CD68+/CD163+/S-100+/CD1α/langerin) in a fibroinflammatory background. The histiocytes demonstrated emperipolesis of lymphocytes, a hallmark feature of Rosai-Dorfman disease (RDD). However, molecular analysis revealed a BRAF V600E mutation of the proliferating histiocytes, highlighting the neoplastic features frequently observed in another non-Langerhans-cell histiocytosis known as Erdheim-Chester Disease (ECD). We consider this case to be a unique presentation of ECD harboring some RDD-like cells with emperipolesis, but not a case of RDD with a BRAF mutation concerning its clinical manifestation (involvement of the heart and bones) and neoplastic features.

Citations

Citations to this article as recorded by  
  • An Autopsied Case of Erdheim-Chester Disease with Severe Cardiovascular Involvement
    Atsushi Matsunashi, Wang Zhipeng, Akihiko Sugimoto, Masakazu Fujimoto, Akihiko Yoshizawa, Ryo Sakamoto, Michihiro Uyama, Kohei Ikezoe, Kiminobu Tanizawa, Tomohiro Handa, Toyohiro Hirai
    Internal Medicine.2025;[Epub]     CrossRef
  • Infantile Rosai-Dorfman Disease With Isolated Brain Lesions Disseminated to the Parenchyma and Intraventricular Ependyma, Alteration of Leukocytes as a Promotion Factor in Immune Defense, and New Proposals: A Case Report and Literature Review
    Nasser Kamalian, Shahmir Kamalian, Mohammad Vasei
    Cureus.2024;[Epub]     CrossRef
  • Emperipolesis in pleural fluid mesothelial cells . A phenomenon not associated with Rosai-Dorfman disease, report of a case
    Diana Sofía Vargas-Lías, Mónica Lizette Serrano-Arévalo, Lara-Torres César, Corredor-Alonso Guillermo Ernesto, Hugo R. Dominguez-malagon
    Ultrastructural Pathology.2024; 48(5): 438.     CrossRef
  • BRAF V600E mutation and high expression of PD-L1 in Rosai-Dorfman disease: case report and review of the literature
    Farnoush M. Moen, Mariam M. Youssef, Mihir Shukla, Mary Lynn Nierodzik, Marius E. Mayerhoefer, Christopher Park
    Journal of Hematopathology.2024; 17(4): 183.     CrossRef
  • Characterizing Rosai-Dorfman disease with [18F]FDG PET/CT: a retrospective analysis of a single-center study
    Jianan Zhang, Ruixue Cui, Jian Li, Xinxin Cao, Yaping Luo
    European Radiology.2023; 33(9): 6492.     CrossRef
  • Atypical skeletal involvement in patients with Erdheim–Chester disease: CT imaging findings
    Zaizhu Zhang, Wei Yu, Wenmin Guan, Qiang Lin, Ali Guermazi
    Orphanet Journal of Rare Diseases.2022;[Epub]     CrossRef
  • BRAF mutation in overlapping form of Erdheim-Chester and Rosai Dorfman diseases: a unique case restricted to the central nervous system
    J. Dufour, B. Mathon, M. Touat, K. Hoang-Xuan, K. Mokhtari, A. Idbaih
    Revue Neurologique.2021; 177(6): 708.     CrossRef
  • Reticulohistiocytoses: a revision of the full spectrum
    A. Bonometti, E. Berti
    Journal of the European Academy of Dermatology and Venereology.2020; 34(8): 1684.     CrossRef
  • Orbital histiocytosis with systemic involvement
    Joaquín J.R. Civit, Davinia Godoy, Alicia Conde, Jorge Arencibia, Ramón Medel, Miguel A. Limeres, Iñigo S. Miguel, José D. Marín, Y. Aguilar, Francesc Tresserra, Francisco Medina
    Saudi Journal of Ophthalmology.2020; 34(4): 319.     CrossRef
  • Coccidioidomycosis with emperipolesis in fine needle aspiration
    Alexandra Grosse, Claudia Grosse
    Cytopathology.2019; 30(4): 451.     CrossRef
  • Bilateral Renal Colic as an Initial Presentation of Erdheim-Chester Disease
    Julien Sarkis, Fady Haddad, Sarah Nasr, Elie Hanna, Ahmad Mroueh, Elie Nemr
    Case Reports in Urology.2019; 2019: 1.     CrossRef
  • Erdheim–Chester disease: description of two illustrative cases involving the lung
    Magda Zanelli, Maxwell Smith, Maria C Mengoli, Lucia Spaggiari, Loredana De Marco, Filippo Lococo, Francesco Puma, Stefano Ascani
    Histopathology.2018; 73(1): 167.     CrossRef
  • 11,957 View
  • 225 Download
  • 12 Web of Science
  • 12 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP